GE HEALTHCARE TECHNOLOGIES INC.

NASDAQ: GEHC (GE HealthCare Technologies Inc.)

Kemas kini terakhir: 10 jam lalu

74.39

-0.06 (-0.08%)

  • 1H -0.08%
  • 5H -1.08%
  • 1B 2.10%
  • 6B -12.48%
  • Tahun Ke Tarikh -5.09%
  • 1T -9.98%
  • 5T 23.98%
Penutupan Terdahulu 74.45
Buka 74.88
Jumlah Dagangan 3,308,428
Purata Dagangan (3B) 4,271,931
Modal Pasaran 34,062,063,616
Harga / Pendapatan (P/E TTM) 15.63
Harga / Pendapatan (P/E Ke hadapan) 18.48
Harga / Jualan (P/S) 1.74
Harga / Buku (P/B) 3.75
Julat 52 Minggu
57.65 (-22%) — 94.80 (27%)
Tarikh Pendapatan 30 Jul 2025
Hasil Dividen (DY TTM) 0.18%
Margin Keuntungan 11.03%
Margin Operasi (TTM) 14.78%
EPS Cair (TTM) 4.76
Pertumbuhan Hasil Suku Tahunan (YOY) 2.70%
Pertumbuhan Pendapatan Suku Tahunan (YOY) 50.80%
Jumlah Hutang/Ekuiti (D/E MRQ) 97.51%
Nisbah Semasa (MRQ) 0.980
Aliran Tunai Operasi (OCF TTM) 1.78 B
Aliran Tunai Bebas Leveraj (LFCF TTM) 1.58 B
Pulangan Atas Aset (ROA TTM) 5.87%
Pulangan Atas Ekuiti (ROE TTM) 26.44%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Health Information Services (US) Bercampur Bercampur
Health Information Services (Global) Bercampur Bercampur
Stok GE HealthCare Technologies Inc. Menaik Menurun

AISkor Stockmoo

1.1
Konsensus Penganalisis 1.5
Aktiviti Orang Dalam NA
Volatiliti Harga 1.0
Purata Bergerak Teknikal 0.0
Osilator Teknikal 2.0
Purata 1.13

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
GEHC 34 B 0.18% 15.63 3.75
TEM 10 B - - 32.36
HQY 9 B - 74.57 3.96
WAY 7 B - 297.08 2.14
RCM 6 B - - 2.14
PRVA 3 B - 191.25 3.98

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).
Sektor Healthcare
Industri Health Information Services
Gaya Pelaburan Mid Core
% Dimiliki oleh Orang Dalam 0.28%
% Dimiliki oleh Institusi 80.65%

Pemilikan

Nama Tarikh Syer Dipegang
Dodge & Cox 31 Mar 2025 16,585,509
Hotchkis & Wiley Capital Management Llc 31 Mar 2025 5,751,773
Harris Associates L P 31 Mar 2025 5,633,942
105.90105.9097.2097.2088.5088.5079.8079.8071.1071.10Harga Sasaran MedianQ1 '23Q1 '23Q2 '23Q2 '23Q3 '23Q3 '23Q4 '23Q4 '23Q1 '24Q1 '24Q2 '24Q2 '24Q3 '24Q3 '24Q4 '24Q4 '24Q1 '25Q1 '25Q2 '25Q2 '25Q3 '25Q3 '25
Julat 52 Minggu
57.65 (-22%) — 94.80 (27%)
Julat Harga Sasaran
73.00 (-1%) — 89.00 (19%)
Tinggi 89.00 (Wells Fargo, 19.64%) Beli
89.00 (Citigroup, 19.64%) Beli
Median 85.00 (14.26%)
Rendah 73.00 (UBS, -1.87%) Pegang
Purata 83.43 (12.15%)
Jumlah 5 Beli, 2 Pegang
Harga Purata @ Panggilan 68.55
Syarikat Tarikh Harga Sasaran Panggilan Harga @ Panggilan
Citigroup 09 Jul 2025 89.00 (19.64%) Beli 75.51
30 Apr 2025 86.00 (15.61%) Beli 70.33
Morgan Stanley 06 May 2025 78.00 (4.85%) Pegang 67.09
UBS 05 May 2025 73.00 (-1.87%) Pegang 69.37
Evercore ISI Group 01 May 2025 85.00 (14.26%) Beli 67.67
Goldman Sachs 01 May 2025 82.00 (10.23%) Beli 67.67
Wells Fargo 01 May 2025 89.00 (19.64%) Beli 67.67
Piper Sandler 23 Apr 2025 88.00 (18.30%) Beli 64.89

Tiada data dalam julat masa ini.

  • 3M
Tarikh Jenis Butiran
07 Jul 2025 Pengumuman GE HealthCare to announce second quarter 2025 results on July 30, 2025
01 Jul 2025 Pengumuman GE HealthCare announces cash dividend for second quarter of 2025
24 Jun 2025 Pengumuman FDA Approves Expanded Indications for GE HealthCare’s Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer’s Patients
23 Jun 2025 Pengumuman GE HealthCare enhances cardiac diagnostics with innovative molecular imaging solutions showcased at SNMMI 2025
21 Jun 2025 Pengumuman GE HealthCare drives innovation in theranostics with latest technological advances
20 Jun 2025 Pengumuman AI Tools That Talk, Scan, and Save Lives Are Reshaping the Investment Landscape
19 Jun 2025 Pengumuman Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine
12 Jun 2025 Pengumuman GE HealthCare advances precision care with MIM Encore™ to deliver next-generation digital imaging and workflow solutions
02 Jun 2025 Pengumuman PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer
30 May 2025 Pengumuman Updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Recommend Use of FES PET Imaging for Lobular Breast Cancer
16 May 2025 Pengumuman New Healthcare AI Models Could Reshape Everything From Burnout to Diagnostics
15 May 2025 Pengumuman GE HealthCare launches CleaRecon DL, introducing AI-based 3D reconstruction to the interventional suite
13 May 2025 Pengumuman GE HealthCare Announces FDA Approval of Pediatric Indication for Optison Ultrasound Enhancing Agent
13 May 2025 Pengumuman GE HealthCare and Raydiant Oximetry accelerate innovation in fetal oxygen saturation technology
12 May 2025 Pengumuman GE HealthCare unveils ultra-premium, high-performance gradient 1.5T MRI system
05 May 2025 Pengumuman AI Healthcare Boom Gains Speed as Regulators and Innovators Align
02 May 2025 Pengumuman ESTRO 2025 Congress: GE HealthCare to expand its radiation oncology portfolio and introduce new AI-enabled solutions
30 Apr 2025 Pengumuman GE HealthCare reports first quarter 2025 financial results
28 Apr 2025 Pengumuman GE HealthCare management to present at upcoming investor conferences
24 Apr 2025 Pengumuman GE HealthCare to feature latest advancements in diagnostic accuracy and patient-centered breast care at SBI 2025 Breast Cancer Imaging Symposium
17 Apr 2025 Pengumuman GE HealthCare to announce first quarter 2025 results on April 30, 2025
Papar semua
Hasil Dividen (DY TTM) 0.18%
Purata Hasil Dividen 2T 0.13%
Nisbah Pembayaran 2.63%
Jangkaan Pembayaran Dividen Seterusnya Feb 2026
Tarikh EX Tarikh Pengumuman Tarikh Pembayaran Perincian
25 Jul 2025 01 Jul 2025 15 Aug 2025 0.035 Tunai
25 Apr 2025 27 Mar 2025 15 May 2025 0.035 Tunai
14 Jan 2025 21 Nov 2024 14 Feb 2025 0.035 Tunai
18 Oct 2024 18 Sep 2024 15 Nov 2024 0.03 Tunai
19 Jul 2024 26 Jun 2024 15 Aug 2024 0.03 Tunai
18 Apr 2024 22 Mar 2024 15 May 2024 0.03 Tunai
12 Jan 2024 08 Dec 2023 15 Feb 2024 0.03 Tunai
19 Oct 2023 22 Sep 2023 15 Nov 2023 0.03 Tunai
20 Jul 2023 23 Jun 2023 15 Aug 2023 0.03 Tunai
22 May 2023 25 Apr 2023 15 Jun 2023 0.03 Tunai

Hasil Dividen Tahunan

Tahun Dividen Tahunan ($) Kekerapan/Tahun Hasil %
2025 0.105 3 0.14
2024 0.120 4 0.15
2023 0.090 3 0.12
77.7477.7476.0676.0674.3974.3972.7172.7171.0471.04Jul 3Jul 3Jul 7Jul 7Jul 8Jul 8Jul 9Jul 9Jul 10Jul 10Jul 11Jul 11Jul 14Jul 14Jul 15Jul 15

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

10010075755050252500RSI (14H)
2.0002.0001.5001.5001.0001.0000.5000.5000.0000.000MACD (12, 26, 9)

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2025 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda